A Randomized, Placebo Controlled, Double Masked Phase IB Study Evaluating the Safety and Antiviral Activity of Aprepitant, a Neurokinin-1 Receptor Antagonist in HIV-1 Infected Adults
P. Tebas, F. Tuluc, J. Barrett, Wayne Wagner, Deborah R. Kim, Huaquing Zhao, R. Gonin, J. Korelitz, S. Douglas
PLoS ONE